136 related articles for article (PubMed ID: 10362360)
1. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin.
Xue LY; Qiu Y; He J; Kung HJ; Oleinick NL
Oncogene; 1999 Jun; 18(22):3391-8. PubMed ID: 10362360
[TBL] [Abstract][Full Text] [Related]
2. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells.
Qiu Y; Robinson D; Pretlow TG; Kung HJ
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3644-9. PubMed ID: 9520419
[TBL] [Abstract][Full Text] [Related]
3. Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway.
Liu T; Wu LY; Choi JK; Berkman CE
Int J Oncol; 2010 Apr; 36(4):777-84. PubMed ID: 20198319
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
Beresford SA; Davies MA; Gallick GE; Donato NJ
J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation.
Zhang Z; Zhu W; Zhang J; Guo L
Cancer Biol Ther; 2011 Apr; 11(7):690-8. PubMed ID: 21339702
[TBL] [Abstract][Full Text] [Related]
7. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
Guo L; Chen P; Zhou Y; Sun Y
Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
[TBL] [Abstract][Full Text] [Related]
8. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
9. The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells.
Chen KY; Huang LM; Kung HJ; Ann DK; Shih HM
Oncogene; 2004 Mar; 23(10):1854-62. PubMed ID: 14676838
[TBL] [Abstract][Full Text] [Related]
10. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
Curnock AP; Knox KA
Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
[TBL] [Abstract][Full Text] [Related]
11. Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells.
Jiang X; Borgesi RA; McKnight NC; Kaur R; Carpenter CL; Balk SP
J Biol Chem; 2007 Nov; 282(45):32689-98. PubMed ID: 17823122
[TBL] [Abstract][Full Text] [Related]
12. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.
Dai B; Chen H; Guo S; Yang X; Linn DE; Sun F; Li W; Guo Z; Xu K; Kim O; Kong X; Melamed J; Qiu S; Chen H; Qiu Y
Cancer Res; 2010 Jul; 70(13):5587-96. PubMed ID: 20570899
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism.
Gottschalk AR; Doan A; Nakamura JL; Stokoe D; Haas-Kogan DA
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1221-7. PubMed ID: 16253776
[TBL] [Abstract][Full Text] [Related]
14. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.
He J; Whitacre CM; Xue LY; Berger NA; Oleinick NL
Cancer Res; 1998 Mar; 58(5):940-6. PubMed ID: 9500454
[TBL] [Abstract][Full Text] [Related]
15. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
16. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
17. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
18. ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.
Tørring N; Dagnaes-Hansen F; Sørensen BS; Nexø E; Hynes NE
Prostate; 2003 Jul; 56(2):142-9. PubMed ID: 12746839
[TBL] [Abstract][Full Text] [Related]
19. Promotion of photodynamic therapy-induced apoptosis by stress kinases.
Xue Ly; He J; Oleinick NL
Cell Death Differ; 1999 Sep; 6(9):855-64. PubMed ID: 10510467
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment.
Fujisawa Y; Li W; Wu D; Wong P; Vogel C; Dong B; Kung HJ; Matsumura F
Biol Chem; 2011 Oct; 392(10):897-908. PubMed ID: 21861773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
